Ordinary Index Rebalancing in the Solactive Genomics Index | May 2021

In the ordinary rebalance the following composition will be implemented effective open 17.05.2021:

ADVERUM BIOTECHNOLOGIES INC
AGILENT TECHNOLOGIES INC
ALLOGENE THERAPEUTICS INC
ALNYLAM PHARMACEUTICALS INC
ARROWHEAD PHARMACEUTICALS INC
BIOMARIN PHARMACEUTICAL INC
BLUEBIRD BIO INC
BLUEPRINT MEDICINES CORP
CAREDX INC
CELLECTIS SA
CRISPR THERAPEUTICS AG
DICERNA PHARMACEUTICALS INC
EDITAS MEDICINE INC
GENSCRIPT BIOTECH CORP
GILEAD SCIENCES INC
HOMOLOGY MEDICINES INC
ILLUMINA INC
INTELLIA THERAPEUTICS INC
INVITAE CORP
LUMINEX CORP
MYRIAD GENETICS INC
NANOSTRING TECHNOLOGIES INC
NATERA INC
PACIFIC BIOSCIENCES OF CALIFORNIA INC
PRECISION BIOSCIENCES INC
PROQR THERAPEUTICS NV
QIAGEN NV
REGENXBIO INC
ROCKET PHARMACEUTICALS INC
SANGAMO THERAPEUTICS INC
SAREPTA THERAPEUTICS INC
SORRENTO THERAPEUTICS INC
TAKARA BIO INC
ULTRAGENYX PHARMACEUTICAL INC
UNIQURE B.V.
VERACYTE INC
VERTEX PHARMACEUTICALS INC
VOYAGER THERAPEUTICS INC
WAVE LIFE SCIENCES PTE LTD
ZIOPHARM ONCOLOGY INC